Real World Evaluation of Sotorasib Among Chinese Non-Small Cell Lung Cancer Patients

A Real-world Study: Efficacy and Safety of Anlotinib for Advanced Non-small Cell Lung Cancer(NSCLC)

NCT04871997 ·Status: COMPLETED

A Multi-Centre, Prospective, Non-Interventional Study to Intensively Monitor the Safety of Osimertinib in Clinical Practice Among Chinese NSCLC Patients

NCT03485326 ·Status: COMPLETED

Safety and Efficacy Study of TQ-B3101 in Patients With ROS1-positive Non-Small Cell Lung Cancer (NSCLC)

NCT03972189 ·Status: UNKNOWN ·Phase: PHASE2

Phase II Safety and Efficacy Study of Crizotinib in East Asian Patients With ROS1 Positive, ALK Negative Advanced NSCLC

NCT01945021 ·Status: COMPLETED ·Phase: PHASE2

Real World Study on First Line Crizotinib in ROS1 Rearranged Advanced Non-squamous Non-small Cell Lung Cancer

NCT03646994 ·Status: RECRUITING

Effect of Osimertinib in Ethnic Chinese With EGFR and T790M Mutated NSCLC

NCT03133234 ·Status: COMPLETED

A Study to Compare the Efficacy and Safety of HB1801 to Taxotere in Advanced Non-Small Cell Lung Cancer (NSCLC)

NCT05863325 ·Status: RECRUITING ·Phase: PHASE2

Surufatinib Combined With Toripalimab and Chemotherapy in the Treatment of Non-Small Cell Lung Cancer

NCT05003037 ·Status: UNKNOWN ·Phase: PHASE2

RW Efficacy of Sotorasib in KRAS G12C-mutated Metastatic NSCLC

NCT05273047 ·Status: UNKNOWN

Sotorasib in Previously Treated Locally Advanced or Metastatic NSCLC Subjects With Mutated KRAS p.G12C

NCT05631249 ·Status: RECRUITING ·Phase: PHASE2

Stage III NSCLC RWE in Chinese Patients

NCT04023812 ·Status: COMPLETED

Phase 1/2 Study of HS-10376 in Patients With Non-Small Cell Lung Cancer

NCT05435274 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Study of Safety, Efficacy and Pharmacokinetics of CT-707 in Patients With ALK-positive Non-small Cell Lung Cancer

NCT02695550 ·Status: UNKNOWN ·Phase: PHASE1

Aumolertinib with or Without Chemotherapy As 1st Line Treatment in Locally Advanced or Metastatic Non-Small Cell Lung Cancer with Sensitizing EGFR Mutations

NCT04923906 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Real-world Study of Sunvozertinib Treatment in Advanced EGFR-Mutant NSCLC After EGFR-TKI Treatment Failure

NCT06786208 ·Status: NOT_YET_RECRUITING

Study to Evaluate D-1553 in Subjects With Lung Cancer

NCT05383898 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Clinical Trial of AMG510 in Stage III Unresectable NSCLC KRAS p.G12C Patients and Ineligible for Chemo-radiotherapy

NCT05398094 ·Status: RECRUITING ·Phase: PHASE2

A Study to Compare the Efficacy and Safety of Entrectinib and Crizotinib in Participants With Advanced or Metastatic ROS1 Non-small Cell Lung Cancer (NSCLC) With and Without Central Nervous System (CNS) Metastases

NCT04603807 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Phase Ⅱ Study Assessing the Safety and Efficacy of PLB1004 in EGFR ex20ins Mutation Patients With Advanced and Metastatic Non-small Cell Lung Cancer(NSCLC)

NCT06015503 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Clinical Trial of Neoadjuvant Targeted Treatment to NSCLC Patients

NCT03203590 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

A Phase 2 Study of Osimertinib and S-1 in Treatment Resistant EGFR Mutant NSCLC

NCT05773092 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Induction Lorlatinib in Stage III Non-small Cell Lung Cancer

NCT05740943 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Real-world Observational Study of Targeted Therapy in Patients With Advanced ROS1-positive NSCLC

NCT06694129 ·Status: NOT_YET_RECRUITING

Real-World Effectiveness of Osimertinib for Patients With Non-Small Cell Lung Cancer

NCT05513664 ·Status: UNKNOWN

Survival Outcome of EGFR-TKI in Uncommon EGFR Mutant Advanced NSCLC

NCT04324164 ·Status: RECRUITING